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Endodontic tissue regenerationBioengineered soft tissues on any meaningful scale or complexity must incorporate aspects of the func-
tional tissue, namely a vasculature, providing cells oxygen and nutrients critical for their survival.
However, the ability of tissue engineering strategies to promote a fast revascularization is critically lim-
ited. Particularly in endodontic regenerative therapies, the complicated anatomy of the root canal system,
and the narrow apical access limit the supply of new blood vessels and pulp tissue ingrowth.
Here we characterize the viscoelastic and microstructural properties of a class of injectable hyaluronic
acid (HA) hydrogels formed in situ, reinforced with cellulose nanocrystals (CNCs) and enriched with pla-
telet lysate (PL), and test its ability to promote cells recruitment and proangiogenic activity in vitro. The
incorporation of CNCs enhanced the stability of the materials against hydrolytic and enzymatic degrada-
tion. Moreover, the release of the chemotactic and pro-angiogenic growth factors (GFs) (PDGF and VEGF)
from the PL-laden hydrogels showed an improved sustained profile proportional to the amount of incor-
porated CNCs. The PL-laden hydrogels exhibited preferential supportive properties of encapsulated
human dental pulp cells (hDPCs) in in vitro culture conditions.
Finally, PL-laden hydrogels stimulated chemotactic and pro-angiogenic activity by promoting hDPCs
recruitment and cell sprouting in hDPCs/human umbilical vein endothelial cell co-cultures in vitro, and
in an ex vivo model. These results support the use of the combined system as a scaffold for GFs delivery
and cells recruitment, thereby exhibiting great clinical potential in treating injuries in vascularized
tissues.
Statement of Significance
Innovative strategies for improved chemotactic and pro-angiogenic features of TE constructs are needed.
In this study, we developed an injectable HA/CNC/PL hydrogel with improved structural and biologic
properties, that not only provide a sustained release of chemotactic and proangiogenic GFs from PL
but also enhance the cells’ viability and angiogenic activity. As a result of their unique traits, the devel-
oped hydrogels are ideally suited to simultaneously act as a GFs controlled delivery system and as a sup-
portive matrix for cell culture, recruitment, and revascularization induction, holding great potential for
the regeneration of vascularized soft tissues, such as the dentin-pulp complex.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Host-derived vascularization of implanted 3D structures, is
largely limited by the overall difficulty of host cells to invade andform functional capillaries [1]. This limits the therapeutic potential
of implanted constructs due to lack of nutrient delivery and waste
removal, which result in the formation of a necrotic core [2], while
impair the tissue integration of the grafted constructs. The rapid
induction of angiogenesis represents the major challenge for
endodontic regenerative therapies, in the early stages of dentin-
pulp regeneration [3]. The complicated anatomy of the root canal
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pulp tissue ingrowth. Thus, appropriate engineered constructs
are critically needed to ensure the rapid vascularization upon
implantation, and, therefore, the sustained diffusion of nutrients,
oxygen and metabolites [4], the income of host cells and/or the
survival of transplanted cells.
Biologically relevant hydrogels can address this functional
feature through microfabrication of vessel-like structures, or bio-
logical formation of a vascular system as a result of cell-cell inter-
actions and their cross-communication with growth factors (GFs)
and the extracellular matrix (ECM) [4]. Hydrogels are crosslinked
hydrophilic polymer networks, presenting physical characteristics
similar to soft tissues, such as the dental pulp tissue. Due to hydro-
gels high water content (usually 90%), they provide stable and
flexible wet matrices with adequate porosity for diffusion of
nutrients, and cellular waste [5,6]. Hydrogels can also efficiently
incorporate and release biological agents, important to enhance
the revascularization of the root canal system, and the simultane-
ous regeneration of the dentin-pulp complex [7]. The injectable
hydrogels are of particular interest as they can be delivered
through minimally invasive surgical procedures [8–11], and pro-
duced in situ to conform to the required defect dimensions [12].
Their ability to be easily dispersed inside any closed complex
space, has propelled studies in terms of its potential application
in tissue engineering (TE) approaches with the same complexity
of endodontic regenerative therapies.
Building on a previous study [13], here we propose the
amelioration of a class of in situ injectable hyaluronic acid
(HA) hydrogels based on hydrazone crosslinking between hydra-
zide and aldehyde groups, reinforced with cellulose nanocrystals
(CNCs), and enriched with human platelet lysate (PL). Injectable
HA-based hydrogels compose a promising approach for
endodontic regenerative therapies due to HA structural and
physiological functions within ECM [14], enhancing the biocom-
patibility and biological recognition, while maintaining the
homeostatic integrity of tissues [15]. Based on their chemistry,
these hydrogels can be chemically cross-linked, and functional-
ized with physical or biochemical cues to improve their mechan-
ical strength or promote angiogenesis and/or stem cell
migration, and enhance pulp-dentin regeneration [16]. CNCs
have shown to significantly enhance the stability and mechani-
cal performance of HA hydrogels [13,17]. Moreover, the higher
density of negative charged sulfate groups presented in CNCs’
surface may play a significant role on GFs immobilization and
release profiles, due to their ability to potentially act as sulfated
glycosaminoglycan, which are known to noncovalently bind and
modulate cytokines, GFs, and other ECM proteins [18,19]. PL is
rich in chemotactic and proangiogenic GFs (platelet-derived
growth factor (PDGF), vascular endothelial growth factor (VEGF))
[20], which when incorporated and released from HA-derived
hydrogels is expected to stimulate the migration and prolifera-
tion of encapsulated cells and/or endogenous cells, and induce
the revascularization of the root canal system and simultaneous
pulp tissue ingrowth.
As a proof-of-concept and to test these hypotheses, we incorpo-
rated increasing concentrations of CNCs, and characterized their
morphological and biomechanical/viscoelastic properties. The
in vitro biodegradation of the hydrogels was studied by monitoring
the release of GFs from the polymeric matrix, and by monitoring
the weight loss and swelling properties. The biological perfor-
mance of selected cell/hydrogel was evaluated towards human
dental pulp cells (hDPCs) in vitro. Additionally, we tested the ability
of the PL-laden hydrogels to recruit dental pulp-origin cells, and
promote new vessel-like structures sprouting in vitro and in an
ex vivo model, as a critical prerequisite for dentin-pulp
regeneration.2. Materials and methods
2.1. Production of hydrogels precursors
CNCs, previously isolated from microcrystalline cellulose (MCC)
by sulfuric hydrolysis [13,21], were functionalized by sodium
periodate (NaIO4) oxidation, following the procedure described
elsewhere with slight modifications [22,23].
Hydrazide-modified HA (ADH-HA) was produced according to a
well-established carbodiimide chemistry [24–26], whereas
aldehyde-modified HA (a-HA) was synthesized following a site-
selective NaIO4 oxidation, as described elsewhere, with minor
adaptations [27].
Moreover, PL was collected and processed from different
platelet concentrates, by repeated freezing and melting cycles, as
previously described [28].
The experimental procedures and characterizations of
hydrogels’ precursors are documented in detail in supporting
information.2.2. Development of PL-laden hydrogels
HA hydrogels incorporating CNCs and enriched with PL were
produced through hydrazone cross-linking chemistry between
hydrazide/amine and aldehyde groups (Fig. 1), by adaptation of
a procedure developed elsewhere [13]. The hydrogels were pre-
pared at room temperature by mixing equal amounts of aldehyde
and hydrazide derivatives of HA. A double-barrel syringe, fitted
with a static mixer placed at the outlet, all from Medmix (Ger-
many) was used to produce the injectable hydrogels. For HA/CNCs
hydrogels without PL, barrel A was filled only with ADH-HA, pre-
viously dissolved in Dulbecco’s phosphate buffered saline (DPBS,
Life Technologies, USA) (2% w/v solution) and barrel B with a-
HA (2% w/v) and a-CNCs dispersions at 0.25, 0.5, 0.75, and 1 wt
% concentration. For PL-laden hydrogels, barrel A was filled with
ADH-HA previously dissolved in PL solution, and barrel B had
the same precursors as barrel B for hydrogels without PL. Before
extrusion, the viscous ADH-HA solution was briefly centrifuged
(1 pulses of 10 s) to remove any remaining bubble, capable of
negatively interfere with the polymerization process. The hydro-
gel precursor solutions were then hand extruded into cylindrical
acrylate molds (5 mm in diameter  5 mm in height). The final
PL-laden hydrogels were composed of 1 wt% ADH-HA, 1 wt%
a-HA, and 0.125 to 0.5 wt% a-CNCs in 50 v/v% PL solution. Table 1
summarizes the different conditions used to develop the hydro-
gels, as well the abbreviations used throughout the manuscript.2.3. In situ gelation time
The apparent in situ gelation time of the hydrogels was mea-
sured at room temperature as previously described [25]. A mag-
netic stirring bar was placed in the center of a 100 lL droplet of
ADH-HA aqueous solution (2 wt%) in saline or PL, in a Petri dish
and stirred at 160 rpm using a magnetic stirrer. 100 lL of a-HA
or a-HA/a-CNCs solutions (2 wt% a-HA, 0, 0.5, and1 wt % a-CNCs)
was then added to the ADH-HA drop while stirring. The gelation
time was counted from the mixing point to the gel state, deter-
mined when the solution formed a solid globule after a certain
reaction period, which was defined as the apparent gelation time.
The assay was performed in triplicate for each condition. All the
process was observed in real time using a stereo microscope (Stemi
1000, Zeiss) with a lamp (Schott KL 200, Germany), and recorded
using a digital camera (Canon G12, Japan).
Fig. 1. Schematic representation of the proposed in situ crosslinking system. (1) Preparation of the (A) hydrazide-functionalized hyaluronic acid (ADH-HA) solution with or
without PL and (B) aldehyde functionalized hyaluronic acid (a-HA), with or without aldehyde-modified CNCs (a-CNCs). (2) Preparation of the HA-based hydrogels through the
co-injection of the polymeric solutions, using a double barrel syringe. For biological assays human dental pulp cells (hDPCs) were added to solution (A) before injection in the
molds. (3) Stable hydrogels formed upon cross-link reaction between the hydrazide/amine and carbonyl moieties of precursor components. (4) Incubation of the prepared
hydrogels in physiological conditions, up to 14 days, to assess their biological properties towards hDPCs.
Table 1
Summary of conditions used for the development of injectable HA/CNCs hydrogels.
Formulation
designation
Concentration of
a-HA/ADH-HA (wt%)
Concentration of
a-CNCs (wt%)
Concentration of
PL (v/v%)
0% CNC 0
0.125% CNC 0.125
0.25% CNC 1/1 0.25 –
0.375% CNC 0.375
0.5% CNC 0.5
0% CNC/PL 0
0.125% CNC/PL 0.125
0.25% CNC/PL 1/1 0.25 50
0.375% CNC/PL 0.375
0.5% CNC/PL 0.5
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Cryo-Scanning Electron Microscopy (Cryo-SEM) analysis was
performed to assess the hydrogels’ structure, using a High Resolu-
tion Scanning Electron Microscope with X-Ray Microanalysis and
Cryo-SEM experimental facilities (JEOL JSM 6301F/ Oxford INCA
Energy 350/Gatan Alto 2500). The specimens were rapidly cooled
by plunging it into sub-cooled nitrogen (slush nitrogen), and trans-
ferred under vacuum to the cold stage of the preparation chamber.
Each sample was fractured, exposing their inner structures,sublimated (‘etched’) for 120 s at 90 C, and coated with Au/Pd
by sputtering for 40 s and with a 12 mA current. The sample was
then transferred into the SEM chamber, and imaged at 150 C.
The measurement of pores’ diameter of each sample was per-
formed using ImageJ software. At least 100 pores for each formula-
tion were randomly selected from different SEM images.
2.5. Assessment of the mechanical/viscoelastic properties of hydrogels
The dynamic viscoelastic behavior of developed hydrogels as
function of time was investigated by using a Kinexus Prot Rheome-
ter from Malvern (UK), and a 20 mm diameter parallel plate geom-
etry. Samples were carefully injected in the middle of the base
plate, and covered with oil to avoid dehydration. The experiments
were carried out at 37 C, under constant strain amplitude (1%) and
frequency (1 Hz), for a period of 90 min. The strain used had been
found to be within the linear viscoelastic region for all hydrogels.
At least four different samples were tested for each composition
with the same experimental settings.
2.6. Enzymatic degradation and swelling assays
The enzymatic degradation behaviour of the hydrogels was
tested in simulated physiological conditions to conclude about
their biodegradability and stability, according to their CNCs
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weighed (Wi) and subsequently incubated in 1.2 mL PBS buffer pH
7.4 containing 2.8 U/mL hyaluronidase (HAase) from bovine testes,
Type IV-S (Sigma-Aldrich, USA) at 37 C, under constant agitation
in a horizontal orbital shaker at 180 rpm. At each preselected time
point (0 h, 3 h, 8 h, 22 h and 2, 4, 5, 6, 8, 11 and 12 days), the hydro-
gels were weighed (Wf), and the incubation medium was stored
and replaced for fresh HAase solution. Measurements were per-
formed until complete degradation of the samples and the time
at which the gel disappeared was recorded. The degradation was
calculated using the following equation: hydrogel mass (%) = Wf/
Wi  100%.
The swelling properties of the hydrogels were also analyzed by
assessing their percentage swelling ratio. The prepared hydrogels
(n = 4) were initially weighed (Wi), immersed in PBS (pH 7.4),
and kept at 37 C for 20 days. At different time points (0h, 3 h, 8
h and 22 h and 2, 3, 6, 7, 11, 15 and 20 days), the immersed hydro-
gels were removed, the excess of PBS was absorbed with a filter
paper, and immediately weighed (Wf). Percentage swelling ratio
was expressed as the percentage ratio between the weight of swol-
len gel and fresh gel. It could be derived from: swelling ratio (%) =
Wf Wi/Wi  100%.2.7. Release of pro-angiogenic platelet lysate-origin growth factors
The ability of the developed PL-based hydrogels to release
PDGF-BB and VEGF was assessed by enzyme-linked immunosor-
bent assay (ELISA). The content of these GFs was assessed in super-
natant taken from the incubation solutions, withdrawn and frozen
at 20 C at pre-selected time points, during enzymatic degrada-
tion assays of the PL-based hydrogels. The quantitative measure-
ment of the mentioned GFs was performed using two similar
kits, Human PDGF-BB ELISA Development Kit and Human VEGF ELISA
Development Kit (Peprotech, USA), and according to manufac-
turer’s specifications. The optical density was monitored with mul-
tiwell microplate reader (Synergy HT, Bio-Tek Instruments, USA) at
405 nm with wavelength correction set at 650 nm. Each reading
was performed in duplicate for four samples of each formulation.
The cumulative release of each GF was calculated as follows:
cumulative release ð%Þ ¼ Mt=M0  100%;
where M0 is the amount of VEGF or PDGF preloaded into hydrogel
and Mt is the amount of VEGF or PDGF released from the PL-
loaded hydrogel at time t.
The ability of the HA/PL hydrogels to retain GFs, namely the
entrapment in the hydrogel matrix and the stability over time of
PDGF-BB and VEGF was assessed byWestern Blot. For this purpose,
PL-laden hydrogels were incubated in basal medium for 0, 7, 14
and 21 days at 37 C. After each incubation time, hydrogels were
washed twice in PBS, and frozen at 80 C inside 1.5 mL eppendorf
tubes. Before analysis, HA/PL hydrogels were thawed at room tem-
perature, and 1 mL of extraction buffer (150 mM NaCl (Panreac
Quimica, Spain), 100 mM Tris-HCl, 2 mM ethylenediaminete-
traacetic acid, 1% Triton X-100 (Sigma-Aldrich, Germany), 0.5%
sodium deoxycholate, and 1:100 protease inhibitor cocktail, all
from Sigma-Aldrich (USA)) was added to each hydrogel. After
milling in an ultrasonic processor (VCX-130 PB-220, Sonics, USA)
the hydrogels’ slime was incubated for 1 h at 4 C, under constant
agitation in a horizontal orbital shaker (SC2D000580, SK-O330-
PRO, SCANSCI). Thereafter, the samples were centrifuged for 20
min at 13,500g, and the supernatant was replaced by 30 lL of
0.9% w/v NaCl solution, and 10 lL of loading buffer (4 w/v% SDS
(NZYTech, Portugal), 10 v/v% 2-mercaptoethanol, 20 v/v% glycerol,
0.004 w/v% bromophenol blue, 0.125 M Tris-HCl pH 6.8, all from
Sigma-Aldrich (USA)). Subsequently, the samples were heated at95 C for 5 min, and centrifuged at 13,500g in a gyrospin centrifuge
(ScanSpeed Mini, Labogene, Denmark) for 1 min.
The proteins present in the hydrogel macerate were separated
by electrophoresis in a 12% resolving and 4% stacking SDS-PAGE
gel (Fluka, USA). A 10–250 kDa molecular weight marker (PageRu-
ler Plus Prestained Protein Ladder, Thermo Fisher Scientific, USA)
was used as reference. Following electrophoretic separation, the
proteins were transferred from the SDS-PAGE onto nitrocellulose
membranes (GE Healthcare, UK), using routine wet stage transfer
protocols.
Afterwards, the membranes were blocked in 3% bovine serum
albumin (BSA, Sigma-Aldrich, USA) in tris-buffered saline with
Tween 20 (TBST) buffer (20 mM tris base (Nzytech, Portugal),
150 mM NaCl, 0.1 v/v% Tween 20 (Sigma-Aldrich, USA), pH 7.5)
at room temperature for 1 h. Then, the membranes were incubated
overnight in the primary antibody solution against the target pro-
tein at 4 C. To detect PDGF-BB, membrane was incubated with
anti-mouse PDGF-BB (ab51869, Abcam, UK) 1:200 in blocking buf-
fer. The antibody anti-mouse VEGF-A (ab171828, Abcam, UK) was
diluted in TBST buffer (1:1000), and used to detect VEGF. Then, the
blot was rinsed three times for 5 min with TBST buffer, and incu-
bated in the alkaline phosphatase horse anti-mouse IgG secondary
antibody (AP-2000, Vector Laboratories, USA), diluted in blocking
buffer solution (1:500), for 1 h at room temperature. For signal
development, a colorimetric alkaline phosphatase conjugate sub-
strate (Bio-Rad, USA) was applied to the blot, according to the
manufacturer’s recommendation. Lastly, the blot was rinsed three
times for 5 min with TBST buffer, followed by imaging and data
analysis. This assay was performed in duplicate.2.8. Expansion of human dental pulp cells (hDPCs)
Human dental pulp cells (hDPCs) were isolated from human
third molars under the scope of a previous study [29]. These cells
were positive for mesenchymal stem cell markers such as CD73,
CD90, CD105 and CD44 with over 98% of cells expressing these
markers, and negative for the hematopoietic markers CD34 and
CD45 (<1%) [29]. hDPCs were cultured in 75 cm3 flasks with Dul-
becco’s Modified Eagle’s Medium – low glucose (DMEM, Sigma-
Aldrich, USA) and supplemented with 10% fetal bovine serum
(FBS, Life Technologies, USA), and 1% antibiotic/antimycotic (Life
Technologies, USA). The culture medium was replaced every 2
days, and maintained semiconfluent. All cultures were incubated
at 37 C in a 5% CO2 high-humidity environment. hDPCs at passage
6 were used in these studies.2.9. Expansion of human umbilical vein endothelial cells (HUVECs)
Human umbilical vein endothelial cells (HUVECs, Lonza, USA),
were firstly expanded in 75 cm2 flasks previously coated with
0.7% gelatin (gelatin from porcine skin, Type A, Sigma-Aldrich,
USA) solution. Before cells being cultured, the flask was washed
with DPBS to remove the excess of gelatin. Cells were cultured with
endothelial cell basal media (Millipore S.A.S, France) supplemented
with 5 ng/mL rh VEGF, 5 ng/mL rh epidermal growth factor (EGF),
5 ng/mL rh basic fibroblast growth factor (FGF), 15 ng/mL rh
insulin-like growth factor-1 (IGF-1), 50 mg/mL ascorbic acid, 1.0
mg/mL hydrocortisone hemisuccinate, 0.75 U/mL heparin sulfate,
10 mM L-glutamine, and 2% of FBS, all fromMillipore S.A.S (France),
until reaching an adequate number. Medium was replaced every 2
days, and the culture was maintained semiconfluent. All cultures
were incubated at 37 C in a 5% CO2 high-humidity environment.
HUVECs at passage 5 were used in this study.
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The production of the hydrogels was conducted in similar con-
ditions as described in Section 2.2, but under sterile conditions
(Fig. 1). Briefly, a-HA was dissolved in 1 DPBS containing 0.5
and 1 wt% a-CNCs, and ADH-HA was dissolved separately in 1X
DPBS or PL solution, at a concentration of 2 wt% overnight at room
temperature. All solutions were sterilized by UV irradiation (254
nm) for 120 min prior to cell encapsulation. Cultured cells were
detached by trypsin and centrifuged at 300g for 5 min, 22 C. The
obtained cell pellet was resuspended in culture media, counted
using a hemocytometer and finally centrifuged. The supernatant
was discarded and 8  106 of hDPCs per mL were resuspended in
the ADH-HA or ADH-HA/PL solutions. The cell suspension was
thoroughly mixed to homogenize the distribution of the cells
within the matrix. The cells mixture was added to the barrel A of
the double-barrel syringe and the barrel B was filled with a-HA
and a-CNCs. The hydrogel precursor solutions were then carefully
hand extruded into cylindrical Teflon molds (5 mm in diameter
 5 mm in height), and incubated at 37 C for 30 min to form a
solid gel. The final hydrogels’ composition was as indicated in
Table 1, but incorporating a cell cargo of 4  106 hDPCs/mL. The
hydrogels with encapsulated cells were cultured in 24-well plates
in basal media for 1, 3, 7, and 14 days (37 C, 5% CO2) with the
replacement of the culture media twice a week.
2.11. Hydrogel cytotoxicity over encapsulated hDPCS
The metabolic activity of the encapsulated hDPCs was quantita-
tively assessed by Alamar Blue fluorescent assay, according to the
manufacturer’s instructions [30]. At each pre-settled time point,
samples were rinsed twice with PBS and transferred to new non-
adherent 24-well plates. Each sample was incubated in 10% v/v
Alamar Blue (Bio-Rad, England) in warm culture medium for 4 h
at 37 C, in standard culture conditions. Then, 50 mL of supernatant
were transferred to transparent 96-well plates. Four hydrogels of
each condition were analysed, and the fluorescence readings were
performed in triplicate. The fluorescence was measured using a
Synergy HT microplate reader (Bio-Tek Instruments, USA) at exci-
tation and emission wavelength of 530 and 590 nm, respectively.
After the fluorescence readings, the samples were washed with
PBS, transferred to eppendorf tubes containing 1 mL of sterile
ultrapure water and stored at 80 C for further DNA extraction
and quantification.
Cell proliferation was evaluated by quantifying the total
amount of double-stranded DNA present at different culture times.
DNA quantification was performed using the Quant-ITTM PicoGreen
dsDNA Assay Kit (Molecular Probes, Invitrogen, USA), and accord-
ing to the manufacturer’s instructions. Before the analysis, the
samples were thawed at room temperature and sonicated for 3
cycles of 5 s. The fluorescence was measured at an excitation
wavelength of 485/20 nm and at an emission wavelength of
528/20 nm. Four hydrogels of each condition were analysed, and
the fluorescence readings were performed in triplicate for each
sample.
The cell morphology was assessed and studied by staining the
nucleus and actin filaments of the hDPCs after 14 days of culture,
to study the ability of developed hydrogels to support the cell
adhesion. Samples were washed 3 times with PBS, before and after
fixation with 10% (v/v) neutral buffered formalin (ThermoFisher
Scientific, USA) for 30 min at room temperature. Then, samples
were incubated in 0.2% (v/v) Triton X-100 (Sigma-Aldrich,
Germany) prepared in PBS, for 1 h at room temperature and under
constant agitation. After washed with PBS, fixed samples were
incubated in 1 mL of the PBS solution containing 4,6-diamidino-
2-phenyindole dilactate (DAPI, Biotium, USA) 1:1500 v/v, andPhalloidin (Phalloidin–Tetramethylrhodamine B isothiocyanate
from Amanita phalloides Sigma-Aldrich, USA) 1:500 v/v, for 1 h
at room temperature, under agitation. After rinsing in PBS to
reduce background fluorescence, hydrogels were mounted on
microscopic slides and visualized under a confocal microscope
(Leica TCS SP8, Microsystems, Wetzlar, Germany), and representa-
tive micrographs were taken. Each experiment was performed in
duplicate.
2.12. In vitro evaluation of the chemotactic and proangiogenic
properties of the HA/PL hydrogels
The ability of the proposed system to recruit progenitor cells
and promote neovascularization was assessed in in vitro condi-
tions, by analysing the sprouting of encapsulated pure hDPCs pel-
lets and co-cultures of hDPCs and HUVECs. Briefly, cultured cells
were detached by trypsin and, centrifuged at 300g for 5 min, at
22 C. After counting, HUVECs were stained for 20 min with green
CellTrace CFSE dye (C34554, Molecular Probes, Invitrogen, USA) in
dimethylsulfoxide (DMSO, Molecular Probes, Invitrogen, USA)
diluted in PBS 1:1000 v/v, whereas hDPCs were stained in red with
CellTracker CM-Dil dye in DMSO (C7000, Molecular Probes, Invitro-
gen, USA) diluted in PBS 1:500 v/v. A culture medium volume
equivalent to five times the original staining solution was added
to each cell type, and incubated for more 5 min before centrifuga-
tion. Then, HUVECs were mixed with hDPCs at a ratio of 1:1 (total
of 2  105 cells), and pelleted by two successive centrifugation
cycles at 2864g for 5 min, 20 C and, incubated overnight. Likewise,
pure hDPCs pellets containing 2  105 cells were produced as con-
trols. Cell pellets were encapsulated into hydrogels by injecting the
polymeric solutions over the pellets placed in the bottom of the
acrylate moulds (5 mm high  5 mm diameter), and let to poly-
merize for 30 min (37 C, 5% CO2). Hydrogels were then removed
along with the molds (5 mm in diameter  5 mm in height), placed
inside a transwell (VWR, USA), mimicking the natural nutrition
provision of root canal system, and incubated in DMEM medium
up to 3 days. The sprouting was assessed over time by fluorescence
inverted microscope (Axio Observer, Zeiss, Germany). The mea-
surement of the sprouting length of each sample was performed
using ImageJ software. For each fluorescence image, the pellet
was divided into four quadrants and two sprouts were randomly
selected from each quadrant and measured. Hydrogels were pro-
duced in triplicate for each composition.
2.12.1. Immunocytochemistry
At the end of the 3rd day in culture, hydrogels were rinsed 3
times with PBS, before and after fixation with 10% (v/v) neutral
buffered formalin for 30 min at room temperature. Before
immunostaining, samples were permeabilized for 1 h with 0.2%
(v/v) Triton X-100 (Sigma-Aldrich, Germany) prepared in PBS, at
room temperature and under constant agitation. Then, samples
were washed 3 times with PBS to remove remaining residues
and the cells nuclei was counterstained with DAPI 1:1500 v/v for
1 h at room temperature, under agitation. After rinsing in PBS to
reduce background fluorescence, hDPCs pellets were immuno-
stained using primary antibodies against CD90 (mouse anti-
human CD90 APC, Pharmingen, USA, #559869, 1:100), and alex-
afluor 594 donkey anti-mouse (A21203, Invitrogen, USA, 1:1000)
was used as secondary antibody. The coculture pellets were
immuno-stained against CD106 (mouse anti-human CD106
(VCAM-1) PE, Pharmingen, USA, 555647, 1:100) and alexafluor
488 rabbit anti-mouse (A11059, Invitrogen, USA, 1:1000) was used
as secondary antibody, followed by immune-staining of the mes-
enchymal cells present in the co-cultures with CD90 (mouse
anti-human CD90 APC, Pharmingen, USA, #559869, 1:100). Sam-
ples were incubated with the primary antibodies at 4 C overnight.
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3 times with PBS for 15 min. Then, samples were incubated with
fluorescent-labelled secondary antibodies at room temperature
for 1 h, prevented from light exposure. All antibodies were diluted
in antibody dilution buffer (Dako, USA). After washed 3 times,
immunolabeled samples were analysed by confocal laser micro-
scopy (Leica TCS SP8, Microsystems, Wetzlar, Germany).2.13. Ex vivo evaluation of the HA/PL hydrogels ability to promote neo-
vascularization
2.13.1. Chick chorioallantoic membrane assay
Chick chorioallantoic membrane (CAM) assay was conducted to
evaluate the effectiveness of the PL-laden hydrogels to promote
neo-vascularization, according to an optimized adaptation
described by Silva-Correia et al. [31]. White fertilized chicken eggs
(n = 120; Pintobar, Portugal) were incubated at 37 C for 3 days
(Laboratory Incubator model B8420; Termaks). Two small holes
were then created in the longitudinal extremities of the egg to pro-
mote CAM dissociation from the egg shell membrane. A circular
window was also created in the egg shell to assess CAM and
embryo viability. The opening in the egg shell was then sealed with
transparent tape (50  30 mm) to avoid dehydration and the
eggs were incubated again at 37 C until day 10 of embryonic
development. At day 10, the different sterile HA-based formula-
tions discs (1:1 HA/ADH-HA wt%; 4 mm in diameter) denoted
by 0% CNC, 0% CNC w/hDPCs (4  106 cells/mL), 0.25% CNC/PL,
0.25% CNC/PL w/hDPCs (4  106 cells/mL), previously prepared in
similar conditions as described in section 2.10, were implanted
on the CAM. Positive control group for angiogenesis consisted on
sterile filter paper discs (4 mm in diameter) (MN GF-3;
Macherey-Nagel) which were also implanted on the CAM at day
10 of embryonic development. Following implantation, shell open-
ing windows were protected again with transparent tape and the
eggs returned to the incubator at 37 C until day 14 of embryonic
development. All these procedures were performed in a laminar
flow hood to minimize contamination. CAM and underlying
embryos were fixed in ovo with freshly prepared 4% (v/v) formalin
(Thermo Scientific) and subsequently incubated at 80 C for 10
min in an ultra-low freezer. The implanted materials and underly-
ing CAM portions were harvested and transferred to 6-well plates
containing the same fixative solution. Ex ovo images were acquired
at 6.5 magnification using the AxioVision imaging software
(release 4.8; Zeiss) connected to an AxioCAM ICc1 digital camera
(Zeiss) attached to a stereomicroscope (Stemi 2000C; Zeiss). The
excised membranes were transferred to histological cassettes,
embedded in paraffin and serially sectioned in 4 mm-thick sections
using a microtome (Rotary Microtome HM355S, MICROM Interna-
tional GmbH, Walldorf, Germany). Three independent CAM assays
were performed.2.13.2. Blood vessels convergence analysis
The macroscopic evaluation of the angiogenic response was
based on a semiquantitative method described by Silva-Correia
et al. [31]consisting on the ex ovo analysis of blood vessels conver-
gence toward the implanted discs. The ex ovo images obtained at
day 14 of embryonic development were processed using the WCIF
ImageJ software program (US National Institutes of Health) and the
total number of convergent macroscopic blood vessels was blindly
counted by three independent observers using a minimum number
of 8 samples per tested condition. For quantification purposes, the
stereomicroscope images were acquired at a constant magnifica-
tion (6.5), and the image-processed area was maintained
(800  800 pixels).2.13.3. Immunohistochemistry
The CAM histological sagittal 4 mm-thick sections were stained
with hematoxylin solution (Modified Mayer’s Hematoxylin;
Richard-Allan Scientific) and images were acquired under
transmitted microscopy using a Microscope Leica DM750 (Leica;
Germany) attached to a digital camera DMC5400 (Leica, Germany)
connected to Leica Application Suite imaging software (release 4.6;
Leica).
Representative paraffin embedded CAM 4 mm-thick sections
were also submitted to immunohistochemical assay with
SNA-lectin using the streptavidin-biotin peroxidase complex kit
(UltraVision Large Volume Detection System Anti-Polyvalent,
HRP; Lab Vision, Thermo Scientific, CA, USA) to detect chick origin
endothelial cells. Briefly, CAM sections were deparaffinized and
rehydrated in a decreasing series of ethanol (Fisher Chemical,
USA). Then, the samples were exposed to heat-induced antigen
retrieval with 10 mM citrate buffer (pH 6; Merck) for 20 min at
98 C. Endogenous peroxidases were blocked by incubation on a
3% (v/v) hydrogen peroxide solution (H2O2; Panreac Química
SLU) for 10 min and washed with PBS (Sigma-Aldrich, USA). CAM
sections were incubated in protein blocking solution (Ultra V
block; Lab Vision, Thermo Scientific, CA, USA) for 10 min followed
by incubation with the primary antibody raised against lectin
(SNA-lectin); Vector Laboratories, Burlingame, CA, USA) for 1 h at
RT. CAM sections were sequentially washed with PBS and incu-
bated with the streptavidin-peroxidase complex for 10 min. The
immune reaction was noted using 3,30-diaminobenzidine solution
(DAB; Vector Laboratories, Burlingame, USA) as chromogen. The
counterstained was performed with Modified Mayer’s Hema-
toxylin. The histological sections were observed, and images were
acquired at different magnifications using Microscope Leica
DM750 attached to a digital camera DMC5400.
The distinction of the different cells present in the hydrogel/
CAM sections was assessed and studied by staining the hDPCs
and vascular cells with specific cells markers. To this end, repre-
sentative CAM histological sagittal sections (4 mm-thick) were
firstly deparaffinized and rehydrated in a decreasing series of
ethanol (Fisher Chemical, USA). Then, the samples were submit-
ted to a heat-induced antigen retrieval with pre-heated 10 mM
citrate buffer (pH 6; Merck, Germany) for 2 min, and allowed
to cool for 20 min at room temperature. CAM sections were
washed twice for 5 min in 1 tris-buffered saline (TBS) buffer
(100 mM tris base (Nzytech, Portugal), 150 mM NaCl, pH 7.5)
with 0.025% Triton X-100 (Sigma-Aldrich, Germany) and blocked
in 10% normal donkey serum (Sigma-Aldrich, USA) with 1%BSA
in TBS for 1 h at room temperature. Then the slides were incu-
bated in the primary antibody overnight at 4 C, to immuno-
stained the vessels of the CAM against mouse a-smooth muscle
actin (a-SMA, ab18147, Abcam, UK; 1:100) diluted in TBS with
1% BSA. Then, all samples were washed twice with TBS/0.025%
Triton X-100 for 5 min, and incubated with the fluorescent-
labelled secondary antibody alexafluor 488 donkey anti-mouse
(A21202, Invitrogen, USA; 1:1000) diluted in TBS with 1% BSA,
at room temperature for 1 h and prevented from light exposure.
After rinsing twice with TBS/0.025% Triton X-100 for 5 min, the
human mesenchymal cells encapsulated into the hydrogels were
immuno-stained with CD90 (mouse anti-human CD90 APC,
#559869, Pharmingen, USA; 1:100) at room temperature for
1 h. Then, samples were washed 3 times with TBS for 5 min to
remove remaining residues and the cells nuclei were counter-
stained with DAPI 1:1500 v/v for 1 h at room temperature. After
rinsing in TBS to reduce background fluorescence, immunola-
beled samples were mounted and analysed by transmitted and
reflected light microscope (Axio Imager Z1m, Zeiss, Germany).
Each experiment was performed in duplicate.
C.R. Silva et al. / Acta Biomaterialia 77 (2018) 155–171 1613. Statistical analysis
The statistical analysis of data was performed using GraphPad
PRISM version 6.0 (GraphPad Software Inc., CA, USA). One- and
two-way analysis of variance (ANOVA) was performed, followed
by the Tukey posthoc test or the Bonferroni post-test to assess sig-
nificant differences, respectively. Statistical significance and asso-
ciated degree of confidence (p < 0.05) are represented by symbols
stated in the graphs. Results are presented as mean ± standard
error of mean.4. Results
4.1. In situ gelation time
Stable hydrogels were quickly formed upon cross-link reaction
of the precursor components, regardless the formulation
(Fig. 2A). The measurements of the apparent in situ gelation time
of the hydrogels are depicted in the hydrogels with and without
PL. HA/CNCs hydrogels presented gelation time values in the range
of 2.7 ± 0.6 to 19.3 ± 2.1 s (0.5% CNC–0% CNC), while the values
obtained for PL-based hydrogels were between 3.3 ± 0.6 and 127
± 31.3 s for 0.5% CNC/PL and 0% CNC/PL, respectively. In this sense,
the increase of a-CNCs content resulted in the decrease of the
working gelation time (p < 0.05). On the other hand, the incorpora-
tion of PL did not have a significant effect, with the exception of theFig. 2. Macroscopic and microscopic characterization of the developed injectable hydr
hydrogels composed of 2 wt% HA, 0, 0.125, 0.25, 0.375 or 0.5 wt% a-CNCs (from the left to
temperature; n = 3. (C) Cross-sectional cryo-SEMmicrographs of HA/CNCs/PL hydrogels (2
(scale bar 5 lm). (D) Box-plot representation of the pore size distribution in the same fo
One-Way ANOVA followed by the Tukey posthoc test for multiple comparisons.formulation 0% CNC/PL which presented the higher gelation time
(127 ± 31.3 s; p < 0.05).4.2. Hydrogel microstructure
The influence of a-CNCs and PL incorporation on hydrogels’
microstructure were investigated by cryo-SEM. Representative
images of the analyzed cross sections are depicted in Fig. 2C. The
pore sizes tend to increase with the incorporation of increasing
ratios of a-CNCs, peaking for the formulation incorporating 0.25%
a-CNCs (Fig. 2D). Therefore, in the formulations without PL, the
mean pore size ranged from 1.9 to 9.4 lm for 0% CNC and 0.25%
CNC, respectively.
The incorporation of PL resulted in a relatively more organized
and compact structure, presenting a more homogeneous porous
microstructure with significantly smaller pores, ranging from 0.9
to 3.3 lm for 0% CNC/PL and 0.25% CNC/PL, respectively.4.3. Assessment of the mechanical/viscoelastic properties of hydrogels
The mechanical/viscoelastic properties of the hydrogels were
tested by rheology analysis in a physiological-like environment.
The results are presented in Fig. 3 where the elastic modulus
(G0)-time and the loss factor (tan d)-time of all the groups, at the
frequency of 1 Hz, are shown. Hydrogels without PL, exhibited
maximum G0 values that ranged between 410 and 965 Pa, for 0%ogels. (A) Photographs of the HA/CNCs (on the top) and HA/CNCs/PL (at bottom)
the right), and 0% and 50% PL. (B) Gelation time of the developed hydrogels, at room
wt% HA; 0 wt%, 0.25 wt% and 0.5 wt% a-CNCs; 0% and 50% PL). Magnification 5000x
rmulations. N = 100; Symbols denote significant differences for p < 0.001 (***) using
Fig. 3. Mechanical characterization and degradability of the developed injectable hydrogels. Representative (A) elastic modulus (G’)-time, and (B) loss factor (tan d)-time
curves of hydrogels, assessed using a rheometer at 37 C; n = 4. One symbol p < 0.05, two symbols p < 0.01, three symbols p < 0.001 by Two-Way ANOVA followed by
Bonferroni post tests for multiple comparisons. * 0% CNC vs 0.5% CNC; % 0.5% CNC vs 0.5% CNC/PL; # 0.25% CNC vs 0.5% CNC; § 0.25% CNC vs 0.25% CNC/PL; $ 0% CNC/PL vs 0.5%
CNC/PL; & 0% CNC vs 0% CNC/PL; @ 0.25% CNC/PL vs 0.5% CNC/PL. (C) Degradation profile in 2.8 U/mL hyaluronidase solution and (D) swelling ratio profile in PBS at 37 C, n =
5. Statistical analysis described in the supporting information.
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enriched with PL, exhibited G0 values of 9 and 471 Pa for a-CNCs
content 0 and 0.5 wt%, respectively. These results show that the
incorporation of a-CNCs in the HA matrix lead to stiffer hydrogels
(higher G0) indicating that they induce a reinforcement effect by
acting as effective junction elements. Moreover, PL-laden hydro-
gels presented lower G0 values in comparison with formulations
without PL, thus, presenting lower stiffness and higher elasticity.
The tan d represents the ratio between the amount of energy
dissipated by viscous mechanisms (G00) and the energy stored in
the elastic component (G0), giving information about the damping
properties of the material. In the last data point, hydrogels without
PL, exhibited tan d values that ranged between 0.04 and 0.06, for
0.25% CNC and 0% CNC formulations, respectively (Fig. 3B). Hydro-
gels enriched with PL, exhibited tan d values of 0.06 and 0.1 for a-
CNCs content 0.25 and 0.5 wt%, respectively. Despite of PL-laden
hydrogels present slightly higher values, the overall low values
(near zero) are indicative of the highly elastic properties of the
hydrogels and low energy dissipating potential.4.4. Enzymatic degradation and swelling assays
The degradation profile of the hydrogels was obtained as a func-
tion of incubation time in HAase solution, as shown in Fig. 3C. The
statistical analysis is depicted in the supporting information,
Table S1. Overall, the obtained results showed that the incorpora-
tion of both a-CNCs and PL in HA hydrogels influences their stabil-
ity. All hydrogel formulations swelled during the first 8 h of
incubation. After this point in time, some samples (0% CNC, 0.5%
CNC, 0.5% CNC/PL) started undergoing enzymatic degradation,
while the remaining samples swelled up to 22 h of incubation.
The incorporation of CNCs in the hydrogels matrix increased their
resilience to enzymatic degradation; the hydrogels without CNCs
totally degraded after 2 days of incubation, while the formulations
with increasing concentrations of nanoparticles degraded only
after 5, 6 and 12 days, respectively. Regarding the PL-loaded hydro-gels, samples without CNCs completely dissolved after 4 days,
while formulations with increasing CNCs content degraded only
after 11 and 13 days of incubation.
The swelling profile over time was followed up to 21 days of
incubation in PBS at 37 C, as depicted in Fig. 3D, and the statistical
analysis is presented in the supporting information (Table S2).
Hydrogels with higher content of a-CNCs and with/without PL
(0.5 wt% CNC/PL and 0.5 wt% CNC) reached equilibrium within
22 h and 2 days of incubation period and presented a mass
increase of 49.5 ± 0.99% and 45.52 ± 0.33%, respectively. After
2–3 days of incubation, all the hydrogels had reached the swelling
equilibrium. The incorporation of both CNCs and PL decreased the
maximum swelling, with the formulations 0% CNC, 0% CNC/PL and
0.125% CNC presenting a maximum mass increase between 56.30
± 7.40% and 61.68 ± 1.00%, while the remaining formulations pre-
sented a maximum swelling between 38.24 ± 0.18% and 47.98 ±
0.98%. After this point in time, hydrogels’ weight remained approx-
imately unaltered during the 21 days follow up.
Overall, the results from enzymatic degradation and swelling
assays showed that incorporation of both a-CNCs and PL into the
HA hydrogels reduced their degradation behavior and swelling
ability.4.5. Release of pro-angiogenic platelet lysate-origin growth factors
The release of pro-angiogenic GFs from the developed PL-laden
hydrogels incubated in PBS or 2.8 U/mL HAase was quantified by
ELISA. The amount of GFs released from the hydrogels incubated
in PBS was not detectable by ELISA. Nevertheless, the enzymatic
degradation of the hydrogels allowed the release of PL-origin
GFs. The results for the release of VEGF, depicted in Fig. 4A, showed
that the different hydrogels displayed a similar release profile
characterized by an initial ‘‘burst” of protein released up to day
2. After 2 days, the release kinetics reached an apparent plateau,
and a slow and sustained delivery remained up to the maximum
release time of each formulation, with exception of the 0%
Fig. 4. Chemical and functional characterization of the PL-laden hydrogels. (A) Vascular endothelial growth factor (VEGF) and (B) platelet-derived growth factor (PDGF)
release, assessed using the PeproTech ELISA Development kit from PL-laden hydrogels, incubated in hyaluronidase solution (2.8 U/mL), at 37 C; n = 4. The bold circles
represent the three groups of formulations distinguished according to the maximum release time of growth factors. Statistical analysis by Two-Way ANOVA followed by
Bonferroni post tests for multiple comparisons. (C) Western blot analyses of VEGF and PDGF-BB retained in PL-laden hydrogels containing 0, 0.25, or 0.5 wt% of a-CNCs (from
the left to the right), incubated in basal medium for 21 days.
C.R. Silva et al. / Acta Biomaterialia 77 (2018) 155–171 163CNCs/PL samples that ceased the release at day 2. Regarding the
release of PDGF-BB, depicted in Fig. 4B, the profiles showed a sus-
tained release, progressing in a linear way up to day 2 for 0% CNC/
PL hydrogels and day 6 for the remaining formulations. After day 6,
the release profiles reached an apparent plateau.
Overall, the profiles demonstrated a slower release of both GFs.
Although no statistically significant differences were observed
between the formulations, there was a significant difference in
the maximum release time, which is proportional with the amount
of CNCs incorporated in the formulations. In this sense, three
groups of formulations were distinguished according to the maxi-
mum release time of GFs: 0% CNC/PL hydrogels released up to day
2; 0.125%–0.25% CNC/PL samples released for 8 days; and 0.375%–
0.5% CNC/PL hydrogels released up to day 12.
The GFs stability within the hydrogels was also studied over the
incubation time in basal medium by Western Blotting. The results
demonstrated the presence of the specific bands for each GF in
study (Fig. 4C); the dimer of PDGF-BB (49.47 kDa) and the Isoform
L-VEGF165 (40.53 kDa) were present in the majority of the formu-
lations and time points, with a similar intensity of the bands which
slightly decreased with the incorporation of a-CNCs.4.6. Encapsulation of human dental pulp cells
The ability of hydrogels to support cell adhesion and prolifera-
tion and control biochemical and cellular mechanisms is one of the
requirements for TE applications. To examine the capability of the
developed hydrogels enriched with PL to entrap cells and support
their viability, the quantity of DNA and the metabolic activity were
evaluated after 1, 3, 7, and 14 days of culturing. In both the cases,
the incorporation of PL in the hydrogels had a positive effect in the
cells proliferation rate and metabolic activity as shown in Fig. 5.Interestingly, the hDPCs encapsulated in hydrogels containing
0% of a-CNCs demonstrated higher cell content in almost all time
points of culturing (Fig. 5A). However, the cytotoxic effect of CNCs
over hDPCs seems to be overcome by the incorporation of PL. The
PL-laden hydrogels presented much higher hDPCs content for all
the time points. The positive effect of PL incorporation was also
observed through the analysis of the metabolic activity per cell
(Fig. 5B). Overall, the hDPCs remained viable, with constant meta-
bolic levels per cell, throughout the experiment for samples con-
taining PL. In contrast, the formulations without PL presented a
considerable reduction on cell viability, with peaks of metabolic
activity per cell after 7 and 14 days of incubation, for the 0%CNC
and 0.25%CNC formulations.
Regarding the cells morphology and cytoskeleton organization,
the results shown that hDPCs encapsulated into the hydrogels with
incorporated PL were spread within the hydrogel and exhibited
elongated shapes, with pronounced and extended actin filaments
after 7 days of culturing, while only disparate round-shaped and
dispersed cells were found on samples produced without PL
(Fig. 5C). Moreover, 3D reconstruction based on confocal imaging
showed not only the presence of a homogeneous distribution of
the cells in both hydrogels with and without PL but also well-
developed multidimensional networks of cell-to-cell and cell-
matrix contacts throughout the PL-laden hydrogels (Fig. 5D).4.7. In vitro evaluation of the chemotactic and proangiogenic
properties of the HA/PL hydrogels
To assess the effect of the PL-laden hydrogel on hDPCs invasion
or sprouting in 3D, cell pellets containing only hDPCs or a 1:1 ratio
of CM-DiI-labeled hDPCs and CFSE-stained HUVECs were stained
and embedded into the hydrogels, and their respective invasion/
Fig. 5. Cell viability on encapsulated hydrogels. A) DNA content and (B) metabolic activity per cell of hDPCs encapsulated in hydrogels (2 wt% HA; 0, 0.25, or 0.5 wt% a-CNCs;
0 and 50 v/v % PL), after 1, 4, 7, and 14 days in culture, assessed by DNA quantification and Alamar Blue assays, respectively. Symbols denote significant differences for p < 0.05
(*), p < 0.01 (**), and p < 0.001 (***) by Two-Way ANOVA followed by Bonferroni post tests for multiple comparisons; n = 4. (C) Actin filaments stained with phalloidin (red)
and nuclei stained with DAPI (blue) of hDPCs encapsulated in the hydrogels after 7 days of culturing. Scale bar: 75 mm. 3D reconstruction obtained by confocal microscopy of
hDPCs distribution on 0.25% CNC and 0.25% CNC/PL hydrogels, 7 days after encapsulation. Scale bar: 100 mm. (120 lm z-stack). (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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length from hDPCs pellets invading the PL hydrogel increased
throughout the course of the experiment, conversely to pellets in
HA/CNCs hydrogels (Fig. 6B and C). Moreover, at each time point,
the cells invasion was significantly greater in PL-laden hydrogels
(p < 0.001). Likewise, there was also an increase in sprout length
from co-culture pellets embedded in PL-laden hydrogels compared
to HA/CNCs constructs at all 3 days (p < 0.001) (Fig. 6D and E).
Regarding PL-enriched hydrogels, cells invasion was increased in
formulations containing 0.25% of a-CNCs over 3 days, both in
monocultures of hDPCs and co-cultures. hDPCs demonstrated
longer outward migration from co-cultures (173.52 ± 5.49 lm for
0.25% CNC/PL formulation) when compared to pellets only contain-
ing hDPCs (156.38 ± 10.84 lm for 0.25% CNC/PL formulation).
The cells morphology and arrangement in the pellet, was also
analysed after the 3 days of culturing, where pellets were stained
with specific antibodies against mesenchymal and endothelial cells
(CD90 and CD106, respectively). Since a more pronounced cell
sprouting was evidenced in all PL-laden hydrogels samples, the
morphology and distribution of the encapsulated cells was only
assessed for these hydrogels.
The confocal images showed that the sprouts were mainly com-
posed of hDPCs, exhibiting spindle-like morphology and extensive
spreading (Fig. 6F, H). This type of cell behaviour was even more
pronounced in co-cultures, especially in hydrogels formed with
0.25% of a-CNCs (Fig. 6G). Moreover, the monocultures of hDPCspresented centrifugal individual migration of cells while in co-
cultures the sprouts were composed of side by side cells forming
tubular-like structures. Regarding the HUVECs contribution for
the sprouting, confocal micrographs showed that CD106+ cells
were confined to the centre of the pellet and rarely participating
in the formation of the sprouts (Fig. 6F, H). These results were also
confirmed with the analysis of sprouts morphology obtained by 3D
reconstruction based on confocal imaging, available in: https://
youtube/M2b1iMOklJQ.
4.8. Ex vivo evaluation of the HA/PL hydrogels ability to promote neo-
vascularization
To confirm the ability of the injectable system to promote
angiogenesis, an ex vivo CAM assay was performed. The quantifica-
tion of convergent macroscopic blood vessels (Fig. 7A) demon-
strated that there were no significant differences among the
different HA-based formulations tested. However, it was possible
to notice that the filter paper (positive control) exhibited a signif-
icant higher number of convergent macroscopic blood vessels
comparing to the different HA formulations, being this difference
less pronounced for the formulations 0.25% CNC/PL and 0.25%
CNC/PL w/hDPCs.
In Fig. 7B it is depicted the light microscopy images of the
excised CAM sagittal sections with the implants, after 4 days of
implantation and stained with hematoxylin and SNA-lectin.
Fig. 6. Chemotactic and proangiogenic properties of the developed hydrogels. (A) Schematic representation of the steps followed in the sprouting assays. (1) hDPCs and 1:1
hDPCs/HUVECs pellets, previously stained with different markers were placed on the surface of a transwell. (2) An acrylic mold was overlaid and the pellets positioned in the
centre. (3) The polymeric solution with or without CNCs and/or PL was injected over the pellets, and stable hydrogels were formed, while encapsulating the cells pellet. (4)
The pellets-incorporated hydrogels, were incubated in physiological conditions for up to 3 days. Representative fluorescent images of cell pellets sprouting within different
scaffolds at day 3 of (B) hDPCs and a (D) co-culture of hDPCs and HUVECs. Scale bars = 100 mm. Respective average cell invasion length (C, E) quantified over time. Symbols
denote significant differences for p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) by Two-Way ANOVA followed by Bonferroni post tests for multiple comparisons; n = 3. Confocal
fluorescent images of the morphology of (F, G, H) co-culture and (G) hDPCs pellets within PL-laden hydrogels after 3 days of incubation. Scale bars = 100 mm, 75 mm, 20 mm,
respectively.
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any of the tested materials. Also, it was observed that the materials
did not elicit an acute inflammatory response, since there was no
formation of granulation tissue. Moreover, it was observed thatin formulations 0% CNC, 0% CNC w/hDPCs, and 0.25% CNC/PL there
is an interface between the hydrogels and the CAM, but no chick
endothelial cells infiltration occurred. Contrarily, in the 0.25%
CNC/PL w/hDPCs hydrogels it was possible to notice a massive
Fig. 7. Proangiogenic properties of thedevelopedhydrogels in an ex vivomodel. (A)Quantification of themacroscopic blood vessels converging towards the implantedHA-based
hydrogels discs (0%CNC, 0%CNC laden with hDPCs (4x106 cells/mL), 0.25%CNC/PL, and 0.25%CNC/PL laden with hDPCs (4  106 cells/mL)) and the positive control for
angiogenesis, filter paper. Symbolsdenote significant differences forp < 0.05 (*), andp < 0.001 (***) byOne-WayANOVA followedbyTukeypost tests formultiple comparisons;n
= 3. (B) Stereomicroscopy photographs of the explants and corresponding excised hydrogel/CAM sections stainedwith Hematoxylin and SNA-lectin. Representative fluorescent
images of CD90+ (red) and a-SMA+ (green) cells, and their nucleus marked with DAPI (blue). The black arrows indicate infiltrated chick endothelial cells. The dashed lines in the
fluorescent images delimit the hydrogels. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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reorganization of hDPCs, which apparently seems to converge to
the formation of microscopic blood vessels.
Regarding the immunofluorescent images it is visible the
expression of a-SMA by the cells in the CAM blood vessels walls
and in the cell mass infiltrating the 0.25% CNC/PL w/hDPCs hydro-
gels or the filter paper. In the 0% CNC w/hDPCs is visible the homo-
geneous distribution of scattered human CD90+ cells. Remarkably,
the cells infiltrating the 0.25% CNC/PL, arranging in the vicinity of
new primordial microscopic vessels, represented by the circular-
arranged red blood cells within the hydrogel, and expressing a-
SMA were human CD90+. Together, the results suggest that the
addition of PL can have a chemotactic effect, thus potentiating
the migration of cells and formation of new convergent blood
vessels.5. Discussion
The present work describes the amelioration of a class of inject-
able HA-based hydrogels, reinforced with CNCs by incorporation of
PL, aiming the augmentation of chemotactic and pro-angiogenic
activity for the regeneration of vascularized injured tissues. The
combination of HA, CNCs and PL, as herein proposed, produced
an in situ cross-linkable system with several advantages for TE
applications. Being injectable and cross-linked in situ, the system
can easily fit to irregular-shaped defects, while deeply interact
with the preserved tissues. Moreover, it can be administrated using
minimally invasive techniques without requiring surgical inter-
ventions. HA-based biomaterials have demonstrated positive
results for several potential applications in the regeneration of soft
tissues [32], due to its natural similarity to ECM, and important
role in several cellular processes including, cell proliferation, mor-
phogenesis, inflammation, and wound repair [33]. CNCs have been
employed as nanofillers or crosslinkers in biobased strategies,
resulting in composite materials with improved mechanical prop-
erties [13,17]. PL can be used in clinical applications as an autolo-
gous [34,35] or allogenic therapy [36–38]. Further than the
extensive variability in the quality of platelet rich hemoderivative
batches across donors reported by several authors [39–42], the
autologous therapeutic administration of platelet rich hemoderiva-
tive is conditioned by the limitations in whole blood volume yield.
The generation of PL through pooled platelet concentrates from ten
donors, biological qualified for blood transfusion (Decreto-Lei No.
100/2011), is expected to provide more consistent and repro-
ducible clinical outcomes [39,43].
With regard to the gelation time, the hydrogel formulations
formed quickly upon mixing of the two HA derivatives and the a-
CNCs, a characteristic of several hydrazone cross-linked HA hydro-
gels which present typical gelation times within 3–30 s [17,44,45].
CNCs content showed a positive effect on the gelation time of the
hydrogels; the decrease of gelation time was proportional to the
amount of the available aldehyde moieties for cross-linking incor-
porated through a-CNCs. In live tissues, the excessive bleeding
might promote polymeric solution dissolution instead of polymer-
ization. Thus, the fast gelation time observed, while hindering the
manipulation of the polymeric solution shortly after injection and
the post-injection procedures, allows the formation of a stable
matrix which can work as a hemostatic plug.
Regarding the viscoelastic properties, rheological analysis
revealed that the incorporation of a-CNCs in the HA matrix lead
to stiffer hydrogels, inducing a reinforcement effect by acting as
effective junction elements. Previous studies on the reinforcement
of gelatin hydrogels with a-CNCs [22] also reported a significant
improvement in gelatin hydrogels crosslinked with a-CNCs com-
pared to unfilled hydrogels. Hydrogel mechanical properties areimportant for the stability of the material in culture and may also
influence cellular mechanotransduction, which in turn has conse-
quences for cellular behaviors like spreading, migration, and stem
cell differentiation [46].With an increase in substrate stiffness, cells
usually exhibit enhanced cell adhesion [47], spreadingwith defined
actin organization [48], and proliferation [49]. Regarding stem cell
differentiation, cells seem to be tuned mechanically (compliance-
matched) so that they preferentially differentiate on ECMs that
have a mechanical stiffness similar to that of their natural tissues
[50,51]. Thus, the incorporation of variable amounts of a-CNCs into
the polymeric matrix may be a useful tool for tuning the hydrogel
mechanical properties and cells behavior, according to the targeted
tissue. Moreover, PL-laden hydrogels presented lower G0 values,
thus, presenting higher elasticity. This may be explained by the
higher degree of mobility provided by PL protein chemical integra-
tion within the polymeric matrix via amine-aldehyde cross-linking.
The adipic acid hydrazide linker provides a shorter crosslinking dis-
tance and lower degree of mobility, therefore restricting the poly-
mer chain mobility and increasing its stiffness.
The degradation of the developed hydrogels occurred in the
presence of the HAase, the specific enzyme that naturally degrades
HA in vivo [52,53]. It should be noted that in this study we used a
supra-physiologic concentration of HAase, 100-fold greater than in
human plasma (approximately 2.8 U/L [54]), since the degradation
rate of HA, mediated by HAase, can be increased in case of injury,
and to ensure complete gel degradation before HAase inactivation
(this enzyme remains active up to 5 h at 37 C [55]). In this sense,
these HA-based materials have the advantage to be degraded and
release their content in a controlled manner, while providing time
and space stability for new tissue ingrowth. As already shown in
previous studies [13], the degradability of the hydrogels can be
controlled through the incorporation of a-CNCs. The ratio of hydra-
zide/aldehyde in the 0% CNC formulation is noticeably 2:1,
whereby the incorporation of a-CNCs will increase the degree of
cross-linking of the hydrogel matrix, and consequently decrease
the degradation rate. Remarkably, the PL-enriched hydrogels
remained stable for longer periods than hydrogels without PL. Such
reinforcement is attributed to the presence of fibrinogen in the PL
[30,56], as this protein is capable of cross-linking, forming a fibrin
mesh which is not susceptible to degradation by the HAase. In
addition, the amines of the PL proteins can by themselves react
with the aldehyde groups by Schiff’s base reaction, becoming an
integral part of the matrix. These results are in line with previous
studies reported by other authors for HA-based hydrogels
[25,45], demonstrating that the incorporation of CNCs and PL in
the HA matrix could modulate their in vivo resorbable properties
by native environment. Likewise, the swelling profiles showed a
decreasing trend with increasing CNCs and PL content following
the trend previously reported studies on polymeric hydrogels rein-
forced with CNCs [17,22,57]. In fact, the swelling profile of hydro-
gels largely depends on the hydrophilicity of their functional
groups and the cross-linking density of the polymeric matrix
[57], which, as previously discussed, increase with a-CNCs and PL
incorporation. Soft tissue defects must be reliably restored to their
original shape and dimensions in addition to having physiological
function. Swelling property of the hydrogels is crucial for sub-
stance exchange; however, an exceeding swelling behaviour can
result in postoperative volume augmentation and displacement
from the implantation site [58,59]. In endodontic regenerative
therapies, this feature can increase the hydrostatic pressure inside
the root canal system, thus breaking the tooth from contact areas
between cement/resin and dentin/enamel or from existing clefts
in the tooth. Compared to high swelling HA-based hydrogels
[60,61], the lower swelling of the developed bionanocomposite
hydrogels makes them suitable to accurately retain the shape
and form of the final tissue structure.
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PDGF-BB and VEGF from the hydrogels, was detected only after
degradation of the hydrogels in HAase, whereas no detectable
traces of GFs were detected after incubation of the hydrogels in
PBS. The desirable sustained release of GFs identified here may
be due to their sequestration by the microstructural networks as
well as the result of resistance of PL to autolysis. Moreover, the
release of both GFs was proportional with the amount of incorpo-
rated CNCs. As mentioned before, the incorporation of CNCs lead to
a higher crosslinking density, and consequently to a lower degra-
dation rate, which resulted in a slower and longer release of the
GFs by prolonging the entrapment time of the GFs. On the other
hand, the GFs, usually positively charged at physiologic pH, bind
electrostatically to negatively charged polymers. It is known that
sulfated glycosaminoglycans have the ability to noncovalently bind
and modulate cytokines, GFs, and other ECM proteins via electro-
static interactions [18,19]. It was previously demonstrated that
VEGF and PDGF-BB have different affinities to sulphated polymers
[62]. Therefore, the higher density of sulfate groups of CNCs (sulfa-
tion density of 0.37 ± 0.01 mmol/g; supplementary information
S3.1) may play a significant role on the different GFs release trends
observed for these hydrogels. We hypothesize that CNCs can
potentially mimic the sulfated glycosaminoglycans function. In a
recent study, CNCs were shown to create anticoagulant surface
coatings, mimicking the role of heparin [63]. Interestingly, this
electrostatic interaction between CNCs and VEGF or PDGF-BB
was further confirmed by Western Blotting, after GFs being
extracted from the minced hydrogel pellets under denaturing con-
ditions. Overall, the intensity of the bands varied with the incorpo-
ration of a-CNCs, becoming much less intense or almost non-
existent on CNCs-incorporating hydrogels. This may represent a
simple way of adjusting the cell instructive cues of engineered
2D/3D constructs, according with the target applications.
Studies demonstrated the ability of PDGF and VEGF to upregu-
late the migration, and proliferation of hDPCs, the differentiation of
odontoblasts, and to promote the angiogenesis activity [64]. In fact,
to promote the recruitment of endogenous or transplanted cells
and the revascularization of the root canal system, these GFs
should interplay with cytokines in a temporal as spatial controlled
manner. Therefore, the controlled release of GFs through the incor-
poration of CNCs is a real asset to the developed hydrogels.
The ability of hydrogels to support and control biochemical and
cellular mechanisms is essential for TE applications. The hDPCs
constitute an excellent stem cell source for dental tissue regenera-
tion, owing to their high accessibility, proliferative ability, and
clonogenic and multilineage differentiation potential [65–68].
Interestingly, the hDPCs encapsulated in HA hydrogels without
CNCs incorporation, plain or PL-laden demonstrated higher cell
cargo in almost all time points of culturing. Their soft characteristic
and lower cross-linking density, might facilitate faster nutrient dif-
fusion and matrix remodelling, thus promoting cellular activities
such as spreading and migration, as previously reported on other
studies [69,70]. The lower values for hydrogels with 0.25% and
0.5% CNCs content can be associated with a possible cytotoxic
effect of the CNCs over the hDPCs. Some studies corroborate this
theory suggesting that cytotoxic responses can occur at high CNCs
concentrations, with significantly decreased cell viability above
200 mg ml1 of CNCs [71], tissue damage, and inflammatory
responses [72,73]. Remarkably, the adverse effects of CNCs seem
to be overcome by the incorporation of PL into the hydrogels.
Our findings show that incorporation of PL enhanced the prolifer-
ation and metabolic activity of encapsulated hDPCs, regulated by
the growth factor milieu contained within the PL-laden scaffolds.
The content in GFs allows PL to be used as a support for cellular
processes such as chemotaxis [74], cell proliferation [75] and dif-
ferentiation [76,77]. In addition, PL contains fibrinogen (precursorof fibrin), fibronectin and vitronectin which are important for ECM
synthesis and for cells adhesion and migration [30,36]. Previous
works have reported the positive effect of appropriate concentra-
tions of supplemented PL in the proliferation and mineralized dif-
ferentiation of human dental pulp stem cells, both in vitro and
in vivo [78,79]. Thus, the developed hydrogels can be used as a cell
delivery vehicle in TE strategies that also retains the nutritive func-
tions of soluble PL, thereby enabling hDPCs survival, engraftment
and delivery.
After having studied the release of chemotactic and proangio-
genic GFs from PL-laden hydrogels and the ability of the hydrogels
to support cell viability, we have studied the chemotactic and
proangiogenic properties of the developed hydrogels. It has been
shown that endothelial cells, either co-cultured with human mes-
enchymal stem cells (MSCs), perivascular lineages or alone, self-
assembled to form microvascular networks [1,4,80,81]. This ten-
dency becomes more pronounced when these cells are encapsu-
lated in ECM-derived or chemically modified hydrogels following
intrinsic homing mechanisms and cross-talk of cell and biomaterial
[82]. In addition, the presence of GFs and signaling markers such as
VEGF and PDGF can boost the mitogenic effect over cells, and the
microvessel formation process [64,82]. In support of these findings,
we tested PL gel’s effect on hDPCs (which have been shown to con-
tain MSCs populations [78]), invasion in a natural nutrition provi-
sion mimicking environment of the root canal system. It was quite
evident that hDPCs in PL-loaded hydrogels had significantly
greater invasion than in hydrogels without PL. Regarding the co-
cultures, PL-laden hydrogels also led to superior hDPCs sprouting
when compared with HA/CNCs hydrogels, however, the HUVECs
had little contribution within the sprouting cells. On the other
hand, HUVECs seemed to enhance the hDPCs migration and forma-
tion of tubular-like structures. As hypothesized, PL incorporation
influenced the migration of hDPCs; PL hydrogels contains a tar-
geted growth factor milieu that induces migratory activity of
hDPCs with minimal effect on sprouting of HUVECs. Indeed, the
release of GFs from HA matrices has been demonstrated to have
beneficial effects on cell viability and scaffold vascularization
[83,84]. Similarly to the results that Robinson et al. [80] obtained
in his work with MSCs/HUVECs incorporated into a PL hydrogel,
when incorporated into the HA/CNCs hydrogels, PL encouraged
hDPCs sprouting and initial formation of similar neovascular struc-
tures. The presence of in vitro cell-to-cell networks even without a
very defined lumen (Fig. 6G) can be considered an early indicator
of the formation of functionally integrated microvessels-like net-
works. Besides the influence of the PL incorporation, the low stiff-
ness of the PL-loaded hydrogels may have contributed to the
favorable cells invasion discovered here. These results are consis-
tent with previous studies indicating that MSCs invasion is depen-
dent on matrix stiffness with preferential growth in softer
substrates [85–87]. In addition, the hydrogels microstructure also
seems to condition the hDPCs migration. Open porous and inter-
connected networks are essential for cell nutrition, proliferation,
infiltration and migration for tissue vascularization and new tissue
ingrowth [88,89]. The migration peak evidenced in the chemotactic
and proangiogenic assays coincides with the peak of hydrogels’
porosity. Indeed, the preferential spreading observed on 0.25%
CNC/PL formulation can be ascribed to their higher pore size.
Finally, the ability of the injectable system to promote angio-
genesis was also assessed in an ex vivo CAM assay. Several previous
works have reported the pro-angiogenic potential of PL-based
hydrogels [81], and the positive effect of conditioned medium from
hDPCs [90,91] in promoting the sprouting of endothelial cells, by
releasing pro-angiogenic GFs (such as VEGF) that have a paracrine
effect on the vascular cells. The combined effect of PL and hDPCs
incorporation is evident in the present study by the promotion of
the CAM infiltration within the PL-laden hydrogels containing
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the vicinity of new primordial microscopic blood vessels. Primary
cultures isolated from dental pulp contain immature stem/progen-
itor cells together with fibroblasts, endothelial cells, and pericytes
released from the pulp tissue [67]. Moreover, co-cultures demon-
strate that DPCs participate in the formation of more stable blood
vessels by promoting endothelial cells proliferation and migration
covering HUVECs, acting as pericytes [92]. According to our results,
besides expressing mesenchymal stem cell markers, primary iso-
lated hDPCs were also positive for perivascular markers, namely
a-SMA, suggestive of their perivascular origin, as reported in pre-
vious studies [92,93]. In this sense, the incorporation of hDPCs in
this novel injectable system might enhance the revascularization
and new tissue ingrowth.
Overall, we suggest promising results of a novel HA-based
hydrogel enriched with PL that has many of the desired character-
istics needed for targeted vascular regeneration and tissue
ingrowth of injured soft tissues with limited blood supply including
favourable gel density, sustained gel integrity, a superior GFs reten-
tion and release profile, and the ability to promote cells’ survival
and migration. In this sense, endodontic regenerative therapies
can take advantage of this injectable system for the recruitment
of progenitor cells that survived apically in the preserved pulp tis-
sue, and the revascularization of root canal system.
6. Conclusions
In this work, we detail the development of an injectable
HA/CNCs/PL hydrogel, with desirable structural properties and bio-
logical activity. The stability, the porosity, and the dynamic vis-
coelastic behavior were changed by incorporating PL or CNCs,
offering a significant degree of control over the hydrogel. The PL
content significantly improved the viability of the encapsulated
hDPCs, while augmented the hydrogels ability to recruit dental
pulp-origin cells in vitro and promote cells sprouting in an
ex vivo model, through the sustained release of chemotactic and
pro-angiogenic GFs. These results, combined with the fact that
these hydrogels can be easily injected into any desired defect
and crosslinked in situ, clearly suggest the potential of this hydro-
gel in future developments for vascularized TE applications, such
as in regenerative dentistry.
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